Search research articles
Contact Us
Filters
Showing results (1-10 of 22) with videos related to
Page
of 3
Sort By:
Current Opinion in Drug Discovery & Development
|
August 4, 2009
Recent advances in 7-transmembrane receptor research
F D King, S Wilson
Drug Design and Delivery
|
December 1, 1988
From metoclopramide to selective gut motility stimulants and 5-HT3 receptor antagonists
G J Sanger, F D King
Journal of Medicinal Chemistry
|
July 1, 1990
5-Hydroxytryptamine (5-HT3) receptor antagonists. 3. Ortho-substituted phenylureas
J Bermudez, S Dabbs, F D King
Journal of Medicinal Chemistry
|
September 1, 1988
Substituted benzamides with conformationally restricted side chains. 2. Indolizidine derivatives as central dopamine receptor antagonists
F D King, M S Hadley, C M McClelland
Journal of Medicinal Chemistry
|
July 1, 1990
5-Hydroxytryptamine (5-HT3) receptor antagonists. 2. 1-Indolinecarboxamides
J Bermudez, S Dabbs, K A Joiner, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
May 1, 1994
Blockade of human atrial 5-HT4 receptors by SB 207710, a selective and high affinity 5-HT4 receptor antagonist
A J Kaumann, L M Gaster, F D King, et al.
Journal of Medicinal Chemistry
|
December 1, 1985
Substituted benzamides with conformationally restricted side chains. 1. Quinolizidine derivatives as selective gastric prokinetic agents
M S Hadley, F D King, B McRitchie, et al.
Journal of Cardiovascular Pharmacology
|
August 13, 1998
Effects of the novel high-affinity 5-HT(1B/1D)-receptor ligand frovatriptan in human isolated basilar and coronary arteries
A A Parsons, P Raval, S Smith, et al.
Journal of Medicinal Chemistry
|
July 1, 1990
5-Hydroxytryptamine (5-HT3) receptor antagonists. 1. Indazole and indolizine-3-carboxylic acid derivatives
J Bermudez, C S Fake, G F Joiner, et al.
Bioorganic & Medicinal Chemistry
|
February 1, 1996
Azabicyclic indole esters as potent 5-HT4 receptor antagonists
P A Wyman, L M Gaster, F D King, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 22) with videos related to
Sort By:
Page
of 3
Current Opinion in Drug Discovery & Development
|
August 4, 2009
Recent advances in 7-transmembrane receptor research
F D King, S Wilson
Drug Design and Delivery
|
December 1, 1988
From metoclopramide to selective gut motility stimulants and 5-HT3 receptor antagonists
G J Sanger, F D King
Journal of Medicinal Chemistry
|
July 1, 1990
5-Hydroxytryptamine (5-HT3) receptor antagonists. 3. Ortho-substituted phenylureas
J Bermudez, S Dabbs, F D King
Journal of Medicinal Chemistry
|
September 1, 1988
Substituted benzamides with conformationally restricted side chains. 2. Indolizidine derivatives as central dopamine receptor antagonists
F D King, M S Hadley, C M McClelland
Journal of Medicinal Chemistry
|
July 1, 1990
5-Hydroxytryptamine (5-HT3) receptor antagonists. 2. 1-Indolinecarboxamides
J Bermudez, S Dabbs, K A Joiner, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
May 1, 1994
Blockade of human atrial 5-HT4 receptors by SB 207710, a selective and high affinity 5-HT4 receptor antagonist
A J Kaumann, L M Gaster, F D King, et al.
Journal of Medicinal Chemistry
|
December 1, 1985
Substituted benzamides with conformationally restricted side chains. 1. Quinolizidine derivatives as selective gastric prokinetic agents
M S Hadley, F D King, B McRitchie, et al.
Journal of Cardiovascular Pharmacology
|
August 13, 1998
Effects of the novel high-affinity 5-HT(1B/1D)-receptor ligand frovatriptan in human isolated basilar and coronary arteries
A A Parsons, P Raval, S Smith, et al.
Journal of Medicinal Chemistry
|
July 1, 1990
5-Hydroxytryptamine (5-HT3) receptor antagonists. 1. Indazole and indolizine-3-carboxylic acid derivatives
J Bermudez, C S Fake, G F Joiner, et al.
Bioorganic & Medicinal Chemistry
|
February 1, 1996
Azabicyclic indole esters as potent 5-HT4 receptor antagonists
P A Wyman, L M Gaster, F D King, et al.
Page
of 3